Streetbeat News

MGX

Metagenomi Inc.

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Open

1.85

Mkt cap

65M

Volume

562K

High

1.94

P/E Ratio

-0.73

52-wk high

11.86

Low

1.69

Div yield

N/A

52-wk low

1.61

A class action lawsuit has been filed against Metagenomi, Inc. (NASDAQ:MGX) for potential securities law violations. Investors who suffered losses are encouraged to join the lawsuit by November 25, 2024.

Portfolio Pulse from

November 25, 2024 | 5:00 pm

Metagenomi, Inc. is facing a class action lawsuit filed by The Schall Law Firm for alleged violations of federal securities laws related to its IPO. Shareholders with losses are urged to contact the firm.

Portfolio Pulse from

November 25, 2024 | 4:45 pm

Rosen Law Firm is urging investors in Metagenomi, Inc. (NASDAQ: MGX) to secure legal counsel before the November 25, 2024 deadline for a securities class action related to the company's IPO.

Portfolio Pulse from

November 25, 2024 | 4:45 pm

Metagenomi, Inc. (NASDAQ:MGX) is facing a lawsuit for securities law violations. Investors who suffered losses are encouraged to contact Levi & Korsinsky for potential recovery options.

Portfolio Pulse from

November 25, 2024 | 4:15 pm

Shareholders of Metagenomi, Inc. (MGX) who incurred losses are encouraged to contact Levi & Korsinsky for information on a potential class action lawsuit under federal securities laws.

Portfolio Pulse from

November 25, 2024 | 4:00 pm

The Schall Law Firm has filed a class action lawsuit against Metagenomi, Inc. (NASDAQ: MGX) for alleged securities fraud related to its IPO. Investors who bought shares in the IPO are encouraged to join the lawsuit.

Portfolio Pulse from

November 25, 2024 | 3:30 pm

Faruqi & Faruqi, LLP is investigating potential claims against Metagenomi, Inc. (NASDAQ: MGX) and reminds investors of the November 25, 2024 deadline to seek the role of lead plaintiff in a federal securities class action filed against the company.

Portfolio Pulse from

November 25, 2024 | 3:15 pm

Shareholders of Metagenomi, Inc. (NASDAQ:MGX) who incurred losses are encouraged to join a class action lawsuit. The lawsuit aims to recover potential losses under federal securities laws.

Portfolio Pulse from

November 25, 2024 | 12:15 am

A securities fraud class action lawsuit is pending against Metagenomi, Inc. (NASDAQ:MGX). Investors who suffered losses are encouraged to contact Levi & Korsinsky before November 25, 2024, to discuss potential recovery options under federal securities laws.

Portfolio Pulse from

November 24, 2024 | 6:15 pm

The Schall Law Firm has filed a class action lawsuit against Metagenomi Inc. for alleged securities fraud related to its IPO. Investors who purchased Metagenomi's securities are encouraged to participate in the lawsuit.

Portfolio Pulse from

November 24, 2024 | 5:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.